1-64745326-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001366165.2(RAVER2):c.154G>C(p.Glu52Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001366165.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAVER2 | NM_001366165.2 | c.154G>C | p.Glu52Gln | missense_variant | 1/12 | ENST00000294428.8 | NP_001353094.1 | |
RAVER2 | NM_018211.4 | c.154G>C | p.Glu52Gln | missense_variant | 1/12 | NP_060681.2 | ||
RAVER2 | XM_011541706.3 | c.154G>C | p.Glu52Gln | missense_variant | 1/9 | XP_011540008.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAVER2 | ENST00000294428.8 | c.154G>C | p.Glu52Gln | missense_variant | 1/12 | 5 | NM_001366165.2 | ENSP00000294428 | A2 | |
RAVER2 | ENST00000371072.8 | c.154G>C | p.Glu52Gln | missense_variant | 1/12 | 1 | ENSP00000360112 | P2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2022 | The c.154G>C (p.E52Q) alteration is located in exon 1 (coding exon 1) of the RAVER2 gene. This alteration results from a G to C substitution at nucleotide position 154, causing the glutamic acid (E) at amino acid position 52 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.